Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Advances in Drug Research
    Advances in Drug Research
    Advances in Drug Research
    Ebook276 pages8 hours

    Advances in Drug Research

    By Academic Press

    ()

    Read preview

    About this ebook

    Advances in Drug Research, Volume 21 comprises three chapters that deal with the general subject, specific therapeutic class, and chemical family of diverse drugs.
    The first chapter of this book discusses the absorption and distribution of drugs in the lymphatic system. A presentation of the anti-infective quinolones is provided in Chapter 2, while the design and therapeutic potential of peptides are elaborated in Chapter 3.
    Other topics covered include lymphotropic carriers and the lymph uptake mechanism; basis of circulation in lymphatic transport of molecules through various routes of administration; and general aspects and characteristics of quinolone antibacterial agents. The mode of action and mechanisms of resistance of quinolones; potent agonists and antagonists of peptides; and inhibitors of atrial natriuretic factor-degrading enzymes are also deliberated in this text.
    This publication is valuable to drug researchers and students interested in advances in drugs.
    LanguageEnglish
    PublisherAcademic Press
    Release dateOct 22, 2013
    ISBN9781483266886
    Advances in Drug Research

    Related to Advances in Drug Research

    Titles in the series (4)

    View More
    View More

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      The Next Naloxone? Companies, Academics Search For Better Overdose-reversal Drugs

      Apr 10, 2018

      ATLANTA — Dr. Nora Volkow has heard a frightening scenario play out around the country. People are administering naloxone to synthetic opioid drug users who have overdosed. But the antidote doesn’t work well. So they give another dose. And it’s only

      5 min read

    • Article

      Is This The Immortality Pill?

      Dec 13, 2017

      DR MICHAEL ELSTEINis a Sydney-based anti-ageing physician and writer. He is the author of three books, including his latest, The Wellness Guide to Preventing the Diseases of Ageing. He has also designed the app The Diet Guide to Ageing Prevention. Ni

      3 min read

    • Article

      Evidence Still Lacking to Support Ivermectin as Treatment for COVID-19

      Mar 14, 2022

      Randomized controlled trials haven't found ivermectin is beneficial in treating COVID-19, although results for ongoing studies will provide a more definitive answer. Yet, a video presents two weak studies as “powerful” and “overwhelming” evidence tha

      12 min read

    • Article

      The Real Big C

      Feb 1, 2022

      The Real Big C
      1 min read

    • Article

      How Stress Can Cause a Cocaine Relapse

      Apr 11, 2017

      For addicts, even a small amount of stress can trigger a relapse. Now scientists understand how stress causes relapse and how they might be able to combat relapses caused by stress even after they happen. In a new cocaine addiction study conducted in

      3 min read

    • Article

      Mirror-Image Life

      Oct 9, 2023

      Mirror-Image Life
      13 min read

    • Article

      Weak Spot in TB Bacteria Could Mean New Drugs

      Jul 7, 2017

      Researchers have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which could lead to new drugs for treating tuberculosis. Mtb, which currently infects nearly 1.5 billion people worldwide and causes more than 1 milli

      1 min read

    • Article

      Deepening the Research

      Jan 15, 2022

      You’ll often hear people say cannabis science is in its infancy. While it’s true there is much more to learn about the plant, some regions of the world have been studying cannabis intensely for decades. The field of cannabis science was pioneered by

      5 min read

    • Article

      Opinion: Drug Sensitivity And Resistance Testing Could Make ‘Right To Try’ A Real Thing

      Oct 9, 2018

      There's no catalog of available drugs that can help patients pursuing #RightToTry options. An updated technique once developed for cancer might match patients with experimental drugs.

      3 min read

    • Article

      Opinion: Biogen’s Good News On Aducanumab Could ‘Open The Floodgates’ For Alzheimer’s Drugs

      Oct 23, 2019

      After pulling the plug on aducanumab in March, Biogen's announcement that the drug works is likely to cause whiplash among some Alzheimer's patients, researchers, and investors.

      3 min read

    • Article

      Editor’s Letter

      Aug 4, 2020

      Editor’s Letter
      2 min read

    • Article

      Holistic Helpers For Bipolar Disorder

      Nov 21, 2021

      Q My daughter has bipolar disorder and takes medication for it, but still suffers badly with symptoms. Can you recommend any holistic therapies? S.K., via email A Formerly known as manic depression, bipolar disorder affects more than 1 percent of

      4 min read

    • Article

      Depression And A Very Unbalanced Theory

      Nov 27, 2022

      Depression And A Very Unbalanced Theory
      5 min read

    • Article

      The Metabolic Approach

      Nov 21, 2021

      Almost 100 years ago, the German physician, researcher and Nobel Laureate Otto Warburg proposed that the primary cause of cancer is a metabolic dysfunction of the mitochondria. Mitochondria are the cellular powerplants that produce ATP, the energy so

      2 min read

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      Introducing The Nominees For Best Biopharma CEO Of 2018. Vote For Your Favorite!

      Dec 12, 2018

      It’s been a roller-coaster year in biopharma. The Food and Drug Administration set a new record for drug approvals, and investors bought a record number of biotech initial public offerings. But the performance of those IPOs has been mixed and the mos

      3 min read

    • Article

      Loxo Oncology Shows High Tumor Response Rates With Second Genetically Targeted Cancer Drug

      Jun 2, 2018

      Loxo Oncology has earned considerable buzz and a hefty stock market valuation for bringing a genomic-based approach to cancer drug development. The Connecticut biotech’s drugs target highly specific genetic mutations found in cancer cells, regardless

      2 min read

    Reviews for Advances in Drug Research

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Advances in Drug Research - Academic Press

      Enjoying the preview?
      Page 1 of 1